Tumor News and Research

RSS

Researchers develop new method to deliver strong antibiotic drugs more safely

Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow.

25 Sep 2023

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation Incubator in Budapest to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions.

From 3DHISTECH Ltd. 25 Sep 2023

Everyday chemicals linked to increased cancer risk, especially in women

This study identifies links between exposure to chemicals like PFAS, parabens, and phenols and increased cancer risk, particularly among women and across racial groups. The findings spotlight the role of environmental toxins in hormone-related cancers, suggesting new avenues for cancer prevention and mitigation strategies.

24 Sep 2023

Mechanoresilient cancer cells more prone to metastasis

The ability of cancer cells to metastasize, or spread from one part of the body to another, is one of the reasons why cancer can be extremely challenging to treat.

22 Sep 2023

Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials

Tumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying cancer-typical alterations.

22 Sep 2023

Using kinase inhibitors in subsets of colorectal cancer patients

A new editorial paper was published in Oncoscience (Volume 10) on June 27, 2023, entitled, "Kinase-targeted therapy in subsets of colorectal cancer."

22 Sep 2023

Researchers develop novel ultrasound imaging technique to view macrophages in real time

Macrophages are little cells vital to the immune system and could possibly inform cell-based therapies for a variety of medical conditions.

22 Sep 2023

Can COVID-19 vaccines turn the tide on long-haul symptoms?

The study finds that COVID-19 vaccination can significantly reduce symptoms and improve well-being in patients suffering from post-COVID-19 conditions (PCC). Vaccination also lowered systemic markers of inflammation but did not entirely eliminate persistent SARS-CoV-2 antigens, which may continue to contribute to inflammation.

22 Sep 2023

CPRIT awards $2 million to SMU to recruit cancer biology researcher Annika Wylie

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $2 million to recruit Annika Wylie to SMU and fund five years of her research, which focuses on the p53 gene, a naturally occurring tumor suppressor.

21 Sep 2023

Clinical trial hopes to enhance treatment options for women with lethal gynecological cancers

An international clinical trial exploring a new way to treat rare and aggressive gynaecological cancers has launched in Melbourne.

21 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.

21 Sep 2023

Tumor News and Research

Researchers develop new method to deliver strong antibiotic drugs more safely

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Everyday chemicals linked to increased cancer risk, especially in women

Mechanoresilient cancer cells more prone to metastasis

Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials

Using kinase inhibitors in subsets of colorectal cancer patients

Researchers develop novel ultrasound imaging technique to view macrophages in real time

Can COVID-19 vaccines turn the tide on long-haul symptoms?

CPRIT awards $2 million to SMU to recruit cancer biology researcher Annika Wylie

Clinical trial hopes to enhance treatment options for women with lethal gynecological cancers

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

Researchers develop new approach to fighting chemo-resistant small cell lung cancer

Manipulating mitochondrial electron flow enhances immune response, reduces tumor growth

UQ researchers identify novel drug target to overcome cancer drug resistance

Creating CAR-T cells with enhanced immune memory to fight cancer

AI-based tool can assess pathology slides to identify valuable features of clear cell renal cell carcinoma

Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

Study reveals link between oral health and survival among head and neck cancer patients

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News